Vascular smooth muscle cell (VSMC) hypertrophy is a characteristic feature of hypertensive vessels that contributes to abnormal vessel tone and structure. In intact aorta, the contractile agonist angiotensin II (ang II) regulates VSMC mass by stimulating an increase in protein synthesis. An in vitromodel of hypertrophy using cultured rat aortic VSMC is well defined, in which ang II induces a ~hypertrophic growth response~ consisting of an increase in protein synthesis and cell size without changes in DNA synthesis or cell number. There has been considerable interest in identifying the mechanisms and cellular signaling pathways whereby ang II stimulates VSMC hypertrophy. Previous work has shown that ang II activates a variety of second messengers, including Ca2+, protein kinase C (PKC), tyrosine kinases, and mitogen activated protein (MAP) kinases. MAP kinases are key mediators of cell growth and have been shown to regulate ribosomal kinases and initiation factors that are crucial for protein synthesis and hypertrophic and hyperplastic growth responses. Our preliminary data indicate that ang II causes a rapid Ca2+ dependent activation of MAP kinase in VSMC. Thus, the major hypothesis of this proposal is that Ca2+ -dependent Map kinase activation is a key mediator of ang II-induced VSMC hypertrophy. A series of experiments with a synthetic MEK inhibitor will determine whether inhibition of MAP kinases blocks rate limiting steps involved in VSMC protein synthesis and translation (as assessed by the regulation of the translation initiation factor eIF-4F) that are crucial to the ang II-induced hypertrophic growth response. A series of pharmacological, biochemical and molecular studies are designed to identify Ca2+ dependent components of the MAP kinase pathway (Shc, Ras, Raf) that are activated by ang II in VSMC. Finally, cellular mechanisms, by which Ca2+ regulates the MAP kinase pathway will be determined. These studies will concentrate on Ca2+ -dependent forms of PKC and calmodulin by use of pharmacological and antisense oligonucleotide inhibitors of PKC and calmodulin affinity chromatography. The proposed investigations are of fundamental importance and will critically test the major hypothesis. Future development of therapeutic strategies specifically targeted to signaling pathways involved in VSMC hypertrophy may have important clinical implications in the treatment of hypertension and atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL056046-06
Application #
6343550
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Program Officer
Lin, Michael
Project Start
1997-01-01
Project End
2001-12-31
Budget Start
2001-01-01
Budget End
2001-12-31
Support Year
6
Fiscal Year
2001
Total Cost
$92,454
Indirect Cost
Name
University of Alabama Birmingham
Department
Physiology
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Husarek, Kathryn E; Katz, Paige S; Trask, Aaron J et al. (2016) The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice. Vascul Pharmacol 76:28-36
Husarek, Kathryn E; Zhang, Xiaojin; McCallinhart, Patricia E et al. (2016) Isolation of Murine Coronary Vascular Smooth Muscle Cells. J Vis Exp :
Wilson, Kristin; Guggilam, Anuradha; West, T Aaron et al. (2014) Effects of a myofilament calcium sensitizer on left ventricular systolic and diastolic function in rats with volume overload heart failure. Am J Physiol Heart Circ Physiol 307:H1605-17
Wilson, Kristin; Lucchesi, Pamela A (2014) Myofilament dysfunction as an emerging mechanism of volume overload heart failure. Pflugers Arch 466:1065-77
Guggilam, Anuradha; Hutchinson, Kirk R; West, T Aaron et al. (2013) In vivo and in vitro cardiac responses to beta-adrenergic stimulation in volume-overload heart failure. J Mol Cell Cardiol 57:47-58
Olave, Nelida; Nicola, Teodora; Zhang, Wei et al. (2012) Transforming growth factor-? regulates endothelin-1 signaling in the newborn mouse lung during hypoxia exposure. Am J Physiol Lung Cell Mol Physiol 302:L857-65
Trask, Aaron J; Delbin, Maria A; Katz, Paige S et al. (2012) Differential coronary resistance microvessel remodeling between type 1 and type 2 diabetic mice: impact of exercise training. Vascul Pharmacol 57:187-93
Trask, Aaron J; Katz, Paige S; Kelly, Amy P et al. (2012) Dynamic micro- and macrovascular remodeling in coronary circulation of obese Ossabaw pigs with metabolic syndrome. J Appl Physiol (1985) 113:1128-40
Souza-Smith, Flavia M; Katz, Paige S; Trask, Aaron J et al. (2011) Mesenteric resistance arteries in type 2 diabetic db/db mice undergo outward remodeling. PLoS One 6:e23337
Katz, Paige S; Trask, Aaron J; Souza-Smith, Flavia M et al. (2011) Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness. Basic Res Cardiol 106:1123-34

Showing the most recent 10 out of 24 publications